Ischemic stroke patients not receiving life-saving treatment, study finds

Ischemic stroke patients who do not receive intravelous (IV) alteplase, a clot-dissolving medication, are significantly less likely to survive, according to researchers.Read the Original Article

Receive Updates

No spam guarantee.

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to toolbar